About IEC

Fuwen Luo

Title: Chief Physician
Email: fuwenluo@aliyun.com
Major: General Surgery

Education/Working Experience

Professional Experience

1989.9--1995.8Resident Physician, the Second Hospital of Dalian Medical University

1995.9--1999.8    Attending Physician, the Second Hospital of Dalian Medical University

1999.9--2004.8    Associate Chief Physician,the Second Hospital of Dalian Medical University

2004.9—Present   Chief Physician,the Second Hospital of Dalian Medical University,  Liaoning

Education Background

1984.9—1989.7   Bachelor's Degree, Clinical Medicine, Harbin Medical University

1989.9—1992.7   MD, General Surgery,Dalian Medical University

1999.1—2000.2   Visiting Scholar, Karolinska Hospital, Karolinska Institute, Sweden

2006.9—2009.8   PhD,Dalian Medical University

Participation in the Academic Community

Committee Member of Chinese Medical Association

Committee Member of Chinese Medical Doctor Association

Expert of medical accident identification in Liaoning Province

Committee Member ofChinese Medical Doctor Associationofevidence based clinical nutrition group Vice chairman of Liaoning nutrition branch of Chinese Medical Association

Publication

1. Splenic abscess owing to cancer at the splenic flexure: A case report and comprehensive review. Awotar GK,Luo F*, Zhao Z, Guan G, Ning S, Ren J, Liu Y, Wang G, Liu P. Medicine (Baltimore). 2016 Sep;95(38):e4941. doi: 10.1097/MD.0000000000004941.PMID:27661050 (Corresponding author,IF 2.133)

2. Gamallat Y, Meyiah A, Kuugbee ED, Hago AM, Chiwala G, Awadasseid A, Bamba D, Zhang X, Shang X,Luo F*, Xin Y*.Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed Pharmacother. 2016 Jul 19;83:536-541. doi: 10.1016/j.biopha.2016.07.001. IF=2.023 (Co-corresponding author)

3. Chemopreventive effects of aspirin at a glance. Usman MW,Luo F, Cheng H, Zhao JJ, Liu P. Biochim Biophys Acta. 2015 Apr;1855(2):254-63. doi: 10.1016/j.bbcan.2015.03.007. Epub 2015 Apr 2. ReviewCo-corresponding author IF 7.841

4. Fan Z, Jing H, Yao J, Li Y, Hu X, Shao H, Shen G, Pan J,Luo F, Tian X.The protective effects of curcumin on experimental acute liver lesion induced by intestinal ischemia-reperfusion through inhibiting the pathway of NF-κB in a rat model. Oxid Med Cell Longev. 2014;2014:191624. doi: 10.1155/2014/191624. Epub 2014 Aug 20.IF 3.516

5. MG132 alleviates liver injury induced by intestinal ischemia/reperfusion in rats: involvement of the AhR and NFκB pathways.Jing H, Shen G, Wang G, Zhang F, Li Y,Luo F, Yao J, Tian XF.J Surg Res. 2012 Jul;176(1):63-73. doi: 10.1016/j.jss.2011.09.001. Epub 2011 Sep 29 IF 1.936

6. Nurr1 promotes intestinal regeneration after ischemia/reperfusion injury by inhibiting the expression of p21 (Waf1/Cip1).Zu G, Yao J, Ji A, Ning S,Luo F, Li Z, Feng D, Rui Y, Li Y, Wang G, Tian X.J Mol Med (Berl). 2016 Aug 24. [Epub ahead of print] IF 5.107

Research Projects/Grants

1. PI3K small molecule inhibitors targeted therapy for primary liver cancer with PTEN gene deletion. Natural Science Foundation of Liaoning Province.Role:Principal Investigator.(2016.1-2018.12)

2. Effect of composite VEGF chitosan scaffold on the formation of chronic lower limb ischemia. Natural Science Foundation of Liaoning Province.Role:Principal Investigator.(2012.1-2014.12)

3.  PI3K related research of breast cancer.Natural ScienceFoundation of China. Role: Co-Principal Investigator.(2014.1-2017.12)

AdmissionPlan/Requirements

Admission plan:3 foreign postgraduates

English required:English is native language orofficial language.